Trials / Withdrawn
WithdrawnNCT01071694
QOLBET Quality Of Life in Patients With Early Relapsing-remitting Multiple Sclerosis Treated With BETaferon® in Korea
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is to describe the quality of life of Korean patients with early relapsing-remitting multiple sclerosis during the initial 1 year of treatment with Betaferon with several validated questionnaires.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Interferon beta 1-b (Betaferon/Betaseron, BAY86-5046) | Patients receiving Betaferon according to routine clinical practice |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2010-02-19
- Last updated
- 2012-04-16
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01071694. Inclusion in this directory is not an endorsement.